Accure Therapeutics S.L.
Spain
1 December 2019 - 30 November 2020
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Accure Therapeutics S.L. published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 1 | 0.20 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 1 | 0.20 | |
Top articles by Altmetric score in current window
The matrix metalloproteinase inhibitor IPR-179 has antiseizure and antiepileptogenic effects
Journal of Clinical Investigation
2020-11-03
1 December 2019 - 30 November 2020
International vs. domestic collaboration by Share
- 0% Domestic
- 100% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by Share (0 total)
- Accure Therapeutics S.L., Spain
- Domestic institution
Top 10 international collaborators by Share (12 total)
- Accure Therapeutics S.L., Spain
- Foreign institution
-
Amsterdam UMC, Netherlands
(0)
-
University of Amsterdam (UvA), Netherlands
(0)
-
VU Amsterdam, Netherlands
(0)
-
DZNE Site Magdeburg, Germany
(0)
-
Center for Neuroscience, Netherlands
(0)
-
Otto-von-Guericke University Magdeburg (OVGU), Germany
(0)
-
UCL, United Kingdom (UK)
(0)
-
University of Bonn (Uni Bonn), Germany
(0)
-
Helmholtz Association of German Research Centres, Germany
(0)
-
Leibniz Association, Germany
(0)
Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
